bullfrogai.com Open in urlscan Pro
67.227.192.80  Public Scan

Form analysis
0 forms found in the DOM

Text Content

This website stores cookies on your computer. These cookies are used to improve
your website experience and provide more personalized services to you, both on
this website and through other media. To find out more about the cookies we use,
see our Privacy Policy.

If you decline, we won't track your information when you visit our site. But in
order to comply with your preferences, we'll have to use just one tiny cookie so
that you're not asked to make this choice again.

Cookie Slections
Accept Decline
Technology Solutions
* Case Studies & White Papers
Pipeline Leadership Investors Media Contact Us
Technology Solutions
* Case Studies & White Papers
Pipeline Leadership Investors Media Contact Us


USING ARTIFICIAL INTELLIGENCE
TO STREAMLINE
DRUG DEVELOPMENT


IDENTIFYING UNRECOGNIZED
CORRELATIONS IN CLINICAL DATA


LEVERAGING ANALYTIC TOOLS
THAT GENERATE
ACTIONABLE INSIGHTS







A BEST-IN-CLASS AI ML PLATFORM, LEVERAGED FOR PREDICTIVE ANALYTICS IN DRUG
DEVELOPMENT STRATEGY

Read More


DEVELOPED AT JOHNS HOPKINS UNIVERSITY APPLIED PHYSICS LABORATORY


ALGORITHMS THAT OUTPERFORM TOP 10 ANALYTICS FRAMEWORKS

LEARN MORE about our technology


88%

OF DRUGS IN THE PIPELINE WILL FAIL


CHANGING THE FORMULA OF BIOTECHNOLOGY FAILURE


A GAME CHANGING MODEL THAT FILLS THE GAP BETWEEN SCIENCE & DATA

LEARN MORE about investing


8.5 YEARS

AVERAGE UNTIL READY FOR MARKET


PRECISION MEDICINE EVEN MORE PRECISE


BULLFROG PREDICTS AND ENHANCES PRIMARY STUDY OUTCOME SUCCESS.

LEARN MORE about Our solutions


2.6 BILLION

AVERAGE cost for new drug


OUR MISSION

A clinical-phase Biotechnology company using machine learning to advance
medicine and improve human health.

BullFrog takes a holistic approach toward modeling complex interactions between
biomedical systems and real-world data. BullFrog AI, an emerging digital
biopharma company, is committed to changing that paradigm.

Meet our leadership


CEO CORNER

“Let us help you determine the right patient for the right drug at the right
dose.”

Vin Singh, CEO

Visit the ceo corner


LATEST NEWS

April 21, 2022


THE FSHD SOCIETY IS DEPLOYING POWERFUL AI TECHNOLOGY TO IMPROVE CLINICAL TRIAL
DESIGN FOR FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY

Read More
View all our news


With the bfLEAP™ platform, BullFrog AI discovers therapies that simply wouldn’t
be found with other AI platforms. This innovative technology is unmatched and
sets a new bar for precision medicine.

Learn more about our technology
 * Terms of Use
 * Privacy Policy
 * DMCA Notice
 * Accessibility Statement

Follow us

© 2022 Bullfrog AI Holdings, Inc.

Website design by Mentus
 

Let's talk